Literature DB >> 9134445

A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure.

S R Wenneberg1, R H Schneider, K G Walton, C R Maclean, D K Levitsky, J W Salerno, R K Wallace, J V Mandarino, M V Rainforth, R Waziri.   

Abstract

Cardiovascular responses to stress reactivity has been proposed as a risk factor for hypertension. In this study, we evaluated the effects of stress reduction on both laboratory cardiovascular reactivity and ambulatory blood pressure in real life on 39 normotensive male subjects who were pretested for ambulatory blood pressure and cardiovascular reactivity to stress using a battery of laboratory stressors. Thereafter, subjects were randomly assigned to practice either the Transcendental Meditation (TM) technique or a cognitive-based stress education control (SEC) for four months. After 4 months, there was no change in cardiovascular response to stressors between the TM and control groups. However, the subjects regularly practicing TM demonstrated a significant reduction of 9 mm Hg (p < .04) in average ambulatory DBP compared to controls. Since ambulatory BP monitoring has been shown to be a better predictor of cardiovascular complications of hypertension than clinic BP, this finding may have important implications for primary prevention of CVD in normotensive subjects.

Entities:  

Mesh:

Year:  1997        PMID: 9134445     DOI: 10.3109/00207459708988461

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  32 in total

1.  Impact of transcendental meditation on ambulatory blood pressure in African-American adolescents.

Authors:  Vernon A Barnes; Frank A Treiber; Maribeth H Johnson
Journal:  Am J Hypertens       Date:  2004-04       Impact factor: 2.689

2.  Cardiorespiratory synchronization during Zen meditation.

Authors:  Dirk Cysarz; Arndt Büssing
Journal:  Eur J Appl Physiol       Date:  2005-06-07       Impact factor: 3.078

Review 3.  [Does meditation improve the quality of life for patients living with cancer?].

Authors:  Pascal Lamanque; Serge Daneault
Journal:  Can Fam Physician       Date:  2006-04       Impact factor: 3.275

4.  Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.

Authors:  Ravishankar Jayadevappa; Jerry C Johnson; Bernard S Bloom; Sanford Nidich; Shashank Desai; Sumedha Chhatre; Donna B Raziano; Robert Schneider
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

5.  Extending religion-health research to secular minorities: issues and concerns.

Authors:  Karen Hwang; Joseph H Hammer; Ryan T Cragun
Journal:  J Relig Health       Date:  2011-09

6.  Recovery from stress: an experimental examination of focused attention meditation in novices.

Authors:  Amy R Borchardt; Peggy M Zoccola
Journal:  J Behav Med       Date:  2018-05-30

7.  Clinical and Pre-clinical Applications of the Transcendental Meditation Program in the Prevention and Treatment of Essential Hypertension and Cardiovascular Disease in Youth and Adults.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2006-08-01

Review 8.  Cardiovascular disease prevention and health promotion with the transcendental meditation program and Maharishi consciousness-based health care.

Authors:  Robert H Schneider; Kenneth G Walton; John W Salerno; Sanford I Nidich
Journal:  Ethn Dis       Date:  2006       Impact factor: 1.847

9.  Is spirituality a critical ingredient of meditation? Comparing the effects of spiritual meditation, secular meditation, and relaxation on spiritual, psychological, cardiac, and pain outcomes.

Authors:  Amy B Wachholtz; Kenneth I Pargament
Journal:  J Behav Med       Date:  2005-08

10.  Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation(®) Program: A Research Review Update.

Authors:  Vernon A Barnes; David W Orme-Johnson
Journal:  Curr Hypertens Rev       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.